Stock OPTN OPTINOSE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus OptiNose, Inc.

Equities

OPTN

US68404V1008

Real-time Estimate Cboe BZX
Other stock markets
 15:02:11 14/05/2024 BST 		5-day change 1st Jan Change
1.13 USD -3.42% Intraday chart for OptiNose, Inc. +12.62% -10.08%
01:12pm Earnings Flash (OPTN) OPTINOSE Posts Q1 Revenue $14.9M, vs. Street Est of $13.7M MT
05-09 OptiNose, Inc. Provides Preliminary Unaudited Earnings Guidance for the Three-Month Period Ended March 31, 2024 CI

Evolution of the average Target Price on OptiNose, Inc.

Price target over the last 5 years

History of analyst recommendation changes

88993.ZHwH3NAvDl_Oak1ygEYbFPZjgifLS6_XrHeKlApNdmQ.PBBQmJpuVg-APj0AynFffMQb7UuME-iBxyjt7mEgLDcQTXeT439NCJ4kAA~422f94270125294d53f3ca6deb074686

Analyst Recommendations on OptiNose, Inc.

Lake Street Adjusts Price Target on OptiNose to $4 From $3, Maintains Buy Rating MT
HC Wainwright Initiates OptiNose With Buy Rating, $5 Price Target MT
Lake Street Initiates OptiNose at Buy Rating With $3 Price Target MT
BMO Capital Adjusts Price Target on OptiNose to $5 From $6, Maintains Outperform Rating MT
Jefferies Assumes OptiNose at Buy with $5 Price Target MT
OPTINOSE : RBC Cuts Price Target on OptiNose to $10 From $17 on Lower Long-Term Sales Estimates; Outperform-Speculative Risk Rating Kept MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.17 USD
Average target price
3.75 USD
Spread / Average Target
+220.51%
High Price Target
5 USD
Spread / Highest target
+327.35%
Low Price Target
3 USD
Spread / Lowest Target
+156.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering OptiNose, Inc.

Lake Street
HC Wainwright
BMO Capital
Jefferies & Co.
RBC Capital Markets

Ratings for OptiNose, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. OPTN Stock
  4. Consensus OptiNose, Inc.